Why the study?
Does the widespread use of thrombolytic agents and aspirin reduce 1-year mortality in patients with acute myocardial infarction?
Population
Patients admitted to the coronary care units at two city hospitals in the community of Goteborg who…
Comparison
Management during period II characterized by… vs Management during period I prior to the…
Design
Cohort
Follow-up
1 year
Authors
Loading...
Mortality reduction under age 70 may support age-stratified approaches; leaves open overall survival benefit from observational data alone.
Does the widespread use of thrombolytic agents and aspirin reduce 1-year mortality in patients with acute myocardial infarction?
The widespread implementation of thrombolysis and aspirin for acute myocardial infarction significantly reduced 1-year mortality in patients under 70 years of age, though overall mortality was not significantly changed.
Herlitz et al. (1998) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: